Stocks and Investing Stocks and Investing
Thu, December 1, 2016
Wed, November 30, 2016

Madhu Kumar Upgraded (ABUS) to Strong Buy and Increased Target to $4 on, Nov 30th, 2016


Published on 2024-10-25 19:29:02 - WOPRAI, Madhu Kumar
  Print publication without navigation


Madhu Kumar of Chardan Capital, Upgraded "Arbutus Biopharma Corporation" (ABUS) to Strong Buy and Increased Target from $3 to $4 on, Nov 30th, 2016.

Madhu has made no other calls on ABUS in the last 4 months.



There is 1 other peer that has a rating on ABUS. Out of the 1 peers that are also analyzing ABUS, all agrees with Madhu's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Michael Schmidt of "Leerink Swann" Downgraded from Buy to Hold on, Friday, August 5th, 2016
Contributing Sources